New hope for kidney transplant patients: drug may cut protein leak
NCT ID NCT07356388
First seen Jan 29, 2026 · Last updated May 08, 2026 · Updated 15 times
Summary
This study tests whether the drug finerenone can lower protein levels in the urine of people who have had a kidney transplant. High protein in urine is a sign of kidney damage. The trial compares finerenone to another drug, dapagliflozin, to see which works better and is safer. About 54 adult kidney transplant patients with proteinuria are taking part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANTATION RECIPIENTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Changhai Hospital
Shanghai, Shanghai Municipality, 200082, China
Conditions
Explore the condition pages connected to this study.